The Importance of Regulating E-Cigarettes in Ireland

Jul.31.2022
The Importance of Regulating E-Cigarettes in Ireland
The Irish tobacco policy group chair supports restricting e-cigarettes to promote public health and reduce teen smoking.

Professor Des Cox, the chairman of the Irish Tobacco Policy Group, has commented on the recent opinion piece in the Wall Street Journal titled "Why We Shouldn't Wage War on E-cigarettes", stating that he believes such a battle should indeed be fought.


In 2013, the government launched a bold plan to reduce Ireland's smoking rate to 5% by 2025, ushering in a smoke-free society. As of 2021, however, 18% of Irish adults are still smokers, rendering this ambitious goal unattainable.


Last week's opinion piece argued that Ireland needs to embrace e-cigarettes to help more people quit smoking, but is there evidence to support this approach?


The Oireachtas Health Committee has released a report on the Public Health (Tobacco and Nicotine Inhaling Products) Bill. In addition to recommending a ban on the sale of electronic cigarettes to those under 18, the committee also suggested prohibiting the sale of all flavors except tobacco, introducing plain packaging, and banning all forms of e-cigarette advertising.


Teenagers


The first issue to be addressed is the relationship between electronic cigarettes and youth. According to the findings report from the European School Survey Project on Alcohol and Other Drugs (ESPAD) released by the TobaccoFree Research Institute in 2020, the use of electronic cigarettes by 16-17 year-olds has increased by 50% since 2015.


According to a recent survey by ASH UK, 39% of teenagers have tried e-cigarettes and 18% are current users. The study also found that the number of children aged 11 to 17 who use e-cigarettes has increased from 11.2% in 2021 to 15.7% in 2022.


Of concern is the simultaneous increase in the use of electronic cigarettes and the consumption of disposable e-cigarette products by young people. According to a report, the use of disposable e-cigarettes by this age group has increased seven-fold from 2020 to 2022. Nearly half of the surveyed teenagers reported seeing e-cigarette promotion and specifically on TikTok. There is an urgent need to strengthen regulations around the marketing of e-cigarettes, especially online marketing.


Last week's article raised concerns that banning flavored e-cigarettes would result in an increase in Ireland's smoking population. However, there is no publicly available evidence to support this claim. On the other hand, there is substantial evidence indicating that flavored products attract young people to purchase them, leading them to believe that e-cigarettes are a harmless product.


Although adults may also be attracted to flavored electronic cigarettes, the risks of teenagers and young people starting to use them may outweigh the benefits of former smokers using flavored electronic cigarettes.


Last week's article claimed that vaping is a gateway to smoking. A comprehensive study on the topic has found that teenagers who have used e-cigarettes are three to five times more likely to start smoking compared to those who have never used e-cigarettes.


There is now irrefutable evidence that we must protect children from the lure of smoking and e-cigarettes. Simply banning the sale of e-cigarettes to children under the age of 18 through the proposed public health bill will not be the ultimate solution; government officials need to consider the recommendations of the Oireachtas committee on the bill.


Based on the available evidence, we suggest that electronic cigarettes should be subject to the same packaging, advertising, and marketing restrictions as traditional tobacco products. Ireland should only allow tobacco-flavored e-cigarettes, which would enable former smokers to continue experiencing the taste of tobacco while limiting their use among adolescents and young adults.


Last year, a systematic review was published which analyzed ten randomized controlled trials to investigate whether electronic cigarettes were an effective tool for smoking cessation. The review found no evidence to suggest that electronic cigarettes were more effective than nicotine replacement therapy (NRT), which is approved and regulated for smoking cessation.


The evidence for electronic cigarettes as a tool for quitting smoking is at best mixed, and healthcare professionals should recommend reliable methods such as NRT that have been proven effective through practice, rather than electronic cigarettes. In January, Ireland released its first national smoking cessation guidelines, which did not recommend electronic cigarettes as a tool for quitting smoking due to insufficient evidence and the uncertainty surrounding these products.


Best advice.


In addition, healthcare professionals need to have confidence that the treatments they recommend to patients are safe in order to suggest effective methods of care. In 2020, the Health Research Council conducted a review of over 361 studies on the risks and benefits of e-cigarettes and found that they have negative effects on the heart and lungs.


Some supporters of using e-cigarettes as a tool to quit smoking claim that they are 95% safer than tobacco products. However, this statement lacks scientific evidence and is based on the opinions of a small group of doctors from 2013, when we knew little about the harmful effects of e-cigarettes. While it is important to acknowledge that e-cigarettes pose less harm than tobacco products, they are not without risk and the public needs to be aware of this fact.


The argument that e-cigarettes reduce harm has been overemphasized, as they are not more effective than validated treatment methods, and there is too much uncertainty regarding their long-term safety. Additionally, research indicates that many e-cigarette users continue smoking. The 2018 Healthy Ireland survey revealed that 4 out of every 10 adults who use e-cigarettes also use traditional cigarettes.


In order for electronic cigarettes to become a viable option in harm reduction strategies, they must prove themselves as safe products regulated by the Health Products Regulatory Authority (HPRA) to aid people in quitting smoking.


In summary, the evidence in 2022 does not support the argument that electronic cigarettes are an effective tool for quitting smoking. Their long-term safety is still a cause for serious concern and it has been proven that they are a gateway to smoking for teenagers.


Until more conclusive research becomes available, healthcare professionals should promote safe and effective smoking cessation methods, such as nicotine replacement therapy (NRT), rather than unproven methods like electronic cigarettes. The good news is that most smokers want to quit, and there is help available. The HSE's www.quit.ie service is staffed by experienced and trained professionals who offer validated smoking cessation assistance.


Note: Professor Des Cox serves as the Chair of the Tobacco Policy Group at the Royal College of Physicians of Ireland and as a Respiratory Medicine Consultant at Crumlin Children's Hospital in Ireland.


I am sorry, as an AI language model, I only perform tasks based on a specific prompt or request. Please provide me with the text that needs to be translated to standard journalistic English.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Several U.S. states have incorporated the September 9, 2020 PMTA filing deadline into eligibility rules for certain vaping products. CrossBar 20K drew attention after appearing on Pennsylvania's 163-entry directory. A broader 2Firsts investigation found that related registration businesses also listed KUMI and CROSSBAR SIX products, with 171 KUMI-related entries across Louisiana, Nebraska and Wisconsin. Corporate records link Scott Silverman to Blue Nine LLC and VR Products I LLC. PMTA compliance expert Mr. K said historical applications and nicotine-analogue products may offer two different approaches to state-directory access.
Regulations
Oct.26